Datasheet: Xcelodose® 600

The importance of accelerating the supply of material into the clinic is well documented. Capsugel’s Xcelodose® system enables the robust, reproducible and precise filling of drug substance directly into capsules. By linking the Xcelodose® system to Aptuit’s solid form screening and crystallization capabilities in West Lafayette, Indiana, it is possible to eliminate the need for many early development activities for Phase 1 studies yet still have a fully characterized API. Furthermore, Aptuit’s crystal in a capsule strategy means you know what you have and can easily move to the next stage of development if your First-in-Man tests are positive. Aptuit’s customers can access this technology within the Aptuit GMP facility at Livingston, Scotland.